127 related articles for article (PubMed ID: 4800785)
1. Components of the kallikrein-kinin system and the spontaneous cold activation of factor VII in human plasma.
Laake K; Gjonnaess H; Fagerhol MK
Acta Pharmacol Toxicol (Copenh); 1973; 33(3):229-40. PubMed ID: 4800785
[TBL] [Abstract][Full Text] [Related]
2. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII.
Gjonnaess H; Fagerhol MK
Scand J Haematol; 1974; 12(3):232-40. PubMed ID: 4831827
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
5. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
6. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
7. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
[TBL] [Abstract][Full Text] [Related]
8. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptives and ascorbic acid.
Rivers JM
Am J Clin Nutr; 1975 May; 28(5):550-4. PubMed ID: 1093379
[TBL] [Abstract][Full Text] [Related]
10. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
Zaki K; Sami G; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
[TBL] [Abstract][Full Text] [Related]
11. Effect of estrogen treatment on coagulation and fibrinolysis in postmenopausal women. With special reference to cold activation of factor VII.
Gjønnaess H; Munkeby I; Frølich W; Vennerød AM; Fagerhol MK
Gynecol Obstet Invest; 1978; 9(2-3):109-23. PubMed ID: 738649
[TBL] [Abstract][Full Text] [Related]
12. Adrenocortical function of patients using oral contraceptives.
Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
[TBL] [Abstract][Full Text] [Related]
13. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
Norris LA; Bonnar J
Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
[TBL] [Abstract][Full Text] [Related]
14. Factor VII activation and oral contraceptives.
Plu-Bureau G; Scarabin PY; Bara L; Malmejac A; Guize L; Samama M
Thromb Res; 1993 May; 70(3):275-80. PubMed ID: 8327993
[TBL] [Abstract][Full Text] [Related]
15. Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens.
Barbosa J; Seal US; Doe RP
J Clin Endocrinol Metab; 1973 Apr; 36(4):706-14. PubMed ID: 4119677
[TBL] [Abstract][Full Text] [Related]
16. Influence of oral contraceptives and pregnancy on constituents of the kallikrein-kininogen system in plasma.
Adam A; Albert A; Boulanger J; Genot D; Demoulin A; Damas J
Clin Chem; 1985 Sep; 31(9):1533-6. PubMed ID: 3849362
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
Spona J; Feichtinger W; Kindermann C; Schneider B; Mellinger U; Walter F; Moore C; Gräser T
Contraception; 1997 Aug; 56(2):67-75. PubMed ID: 9315414
[TBL] [Abstract][Full Text] [Related]
18. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
[TBL] [Abstract][Full Text] [Related]
19. Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents.
Gordon EM; Douglas J; Ratnoff OD
J Clin Invest; 1983 Nov; 72(5):1833-8. PubMed ID: 6355187
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
Kamal I; Zaki K; Rashad S
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]